T-Rex 2X Inverse MSTR Daily Target ETF vs GeneDx Holdings Corp — how do they compare? T-Rex 2X Inverse MSTR Daily Target ETF trades at $10.62, while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). Which is the better fit depends on your goals.
| MSTZ | WGS | |
|---|---|---|
Sector | Leveraged / Inverse | Technology |
52-Week High | $27.92 | $167.51 |
52-Week Low | $3.50 | $34.51 |
Market Cap | — | $1.80B |
Enterprise Value | — | $1.80B |
Trailing returns across standard periods
MSTZ is a leveraged ETF that seeks daily investment results corresponding to 200% of the inverse (opposite) of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bearish position on MSTR, a company known for its large Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from its stated daily objective.
Read more on MSTZ →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →